研究用抗体・試薬市場：製品、技術、適応症、用途、エンドユーザー別-2024～2030年世界予測

研究用抗体・試薬市場規模は、2023年に165億4,000万米ドルと推定され、2024年には185億5,000万米ドルに達し、CAGR 12.02%で2030年には366億2,000万米ドルに達すると予測されています。

研究用抗体は、細菌やウイルスなどの有害物質や抗原に反応するために体内の免疫系が産生するタンパク質です。科学者は、研究目的でこれらの抗体を研究所で合成します。研究所で生産された研究用抗体は特定の抗原に結合し、同定、検出、中和のための目印となります。これらの抗体は、酵素結合免疫吸着測定法（ELISA）、免疫組織化学、フローサイトメトリー、ウェスタンブロッティング、免疫蛍光など、多くの研究業務に不可欠です。科学研究の文脈における試薬とは、化学反応を誘発するため、あるいは反応が起こるかどうかを実験するために利用されるあらゆる物質を指します。調査用試薬には、酵素、溶媒、触媒、緩衝液などがあり、それぞれに明確な用途と使用法があります。試薬は分子生物学研究において重要な役割を果たし、DNA複製、RNA転写、タンパク質合成、細胞溶解などのプロセスを促進します。研究用抗体・試薬市場は、医療、バイオテクノロジー、製薬、学術機関など様々なセグメントで、研究者が多様な生物学的プロセスを研究するために使用する製品、ツール、サービスを指します。研究用抗体・試薬市場の成長には、製薬会社やバイオ製薬会社による研究活動の増加、プロテオミクスやゲノミクス研究の人気の高まりなど、いくつかの要因が寄与しています。個別化医療とタンパク質治療における研究用抗体・試薬の新たな動向は、この市場の上向きの成長を支えています。しかし、研究用抗体・試薬市場の成長は、抗体開発プロセスの高コストや品質への懸念、研究用抗体・試薬の結果の再現性の欠如など、一定の課題に直面しています。一方、研究用抗体・試薬の研究開発の増加や新規バイオマーカーの発見への注目の高まりは、今後数年間の市場成長の可能性を示しています。

製品：標的タンパク質の検出と定量に抗体の人気が高まる

細菌やウイルスなどの異物を検出する専門家であるタンパク質である抗体は、ウェスタンブロッティングやフローサイトメトリーなど、いくつかのイムノアッセイアプリケーションの基本です。モノクローナル抗体（mAbs）などの種類があり、これらは一種の免疫細胞によって産生されるため同一であり、すべて単一の親細胞のクローンであるため、均一性と高い特異性が保証されています。ポリクローナル抗体（pAbs）は、異なるB細胞株から産生され、同一抗原上の異なるエピトープを同定する抗体の混合物となります。組換え抗体は、親抗体の幅広い混合物から得られ、通常、所望の特異性を有するように操作されます。試薬は生化学的アッセイ、遺伝子処理、その他の分子生物学的技術に不可欠です。試薬グループには、溶液のpHを維持する役割を果たす緩衝液など、多くの要素が含まれており、多くの生物学的プロセスにとって不可欠です。酵素は化学反応を促進するタンパク質で、体内の特定の化学物質を分解、結合、変化させるのに役立っています。固定剤は組織を腐敗から守り、組織学や病理学の研究室では有益です。培地」と「血清」は、細胞培養下で細胞に供給される栄養分のことで、「培地」は必須栄養素を供給し、「血清」は細胞の増殖を助ける追加成長因子を供給します。プローブは、主に分子生物学や生化学において、DNAやRNAの特定の配列を検出、同定、分離するために利用されます。溶媒は物質で、通常は液体であり、溶質を溶解して溶液を得るために使用されます。染色・色素は、顕微鏡像のコントラストを高めたり、顕微鏡像を可視化して観察するために使用される化学薬品です。どちらの製品セグメントも研究において重要な位置を占めているが、それぞれ異なる研究ニーズに対応しています。抗体は標的タンパク質の検出や定量に適しており、試薬はDNAやRNAの操作、生化学反応、細胞培養など、より広範な実験技術を促進します。

技術：イムノフェノタイピングのためのフローサイトメトリーにおける研究用抗体・試薬の使用の増加

ELISA（Enzyme-linked Immunosorbent Assay）は、生物学的サンプル中の特定の抗原や抗体を定量・検出するための手順です。ELISAは高感度、特異性、低コストという利点があり、感染症試験や薬剤モニタリングなど様々なセグメントの研究、診断、品質管理アプリケーションに適しています。フローサイトメトリーはレーザーを用いた技術であり、個々の細胞について複数のパラメーターを同時に迅速かつ効率的に測定することができます。免疫学、腫瘍学、血液学、幹細胞研究において、細胞計数、ソーティング、免疫表現型分類、バイオマーカー検出に一般的に使用されています。免疫蛍光法は、蛍光標識抗体を用いて細胞や組織中の特定のタンパク質やその他の生体分子を検出する顕微鏡ベースの技術です。高感度、高特異性、高空間分解能で、固定あるいは生きたサンプル中のタンパク質の発現、局在、相互作用を研究することができます。免疫組織化学は、発色または蛍光マーカーと結合した特異的抗体を用いて、組織切片内のタンパク質を局在化させるために不可欠な方法です。IHCは病理診断、細胞プロセスの調査、創薬研究などに広く用いられています。免疫沈降法は、固体支持ビーズに固定化した特異的抗体を用いて、複雑な混合物から標的タンパク質を単離するために用いられる強力な方法です。IPは、タンパク質-タンパク質相互作用、翻訳後修飾、タンパク質-核酸相互作用の研究に役立ちます。ウェスタンブロッティングは、ゲル電気泳動後、膜上で抗体を用いて検出することで、複雑なサンプル中の特定のタンパク質を分子量に基づいて捕らえる技術です。タンパク質の発現解析、遺伝子サイレンシングや過剰発現実験の検証、診断評価などのツールとして役立ちます。

適応症：感染症における病原体同定のための研究用抗体・試薬の応用拡大

免疫学別の抗体や試薬は、アレルギーや喘息、自己免疫疾患、移植において最も重要です。感染症対策では、研究用抗体を用いて患者の血清中に特定の抗原や抗体が存在することを証明することで、病原体の同定や検出を行う重要なツールとなっています。さらに、試薬はワクチンや抗ウイルス薬試験のためのウイルス培養に不可欠です。神経生物学では、神経変性疾患や脳損傷に焦点を当てた研究が行われており、抗体や試薬を必要としています。研究用抗体は腫瘍学のセグメントに革命をもたらし、モノクローナル抗体ががん細胞に結合し、その成長と増殖を妨げるがんの標的治療に広く用いられています。免疫組織化学におけるその有用性は、腫瘍の詳細なサブタイプ分類を可能にします。幹細胞研究のセグメントでは、抗体は幹細胞の力価や分化状態の決定に不可欠な役割を果たしています。幹細胞の増殖や分化を助けるために、細胞培養では試薬が多用されます。幹細胞研究は、再生医療やクローン治療において着実な進歩を遂げており、その大きな原動力となっているのが、研究用抗体や試薬の用途の進化です。

用途：特定の治療標的に合わせた医薬品開発における研究用抗体・試薬の利用が増加中

医薬品開発において、研究用抗体・試薬は標的の同定、バリデーション、前臨床試験において極めて重要です。これらはタンパク質対象の同定を容易にし、治療用抗体の作製を加速し、薬剤の有効性と安全性の評価をサポートします。ゲノミクス研究は、遺伝子発現解析、クロマチン免疫沈降法（ChIP）、DNAメチル化研究、CRISPR/Cas9遺伝子編集などの技術において、高品質の抗体と試薬に依存しています。これらのツールは、疾患に関与する遺伝子を同定し、遺伝的メカニズムをより深く理解するのに役立ちます。プロテオミクス研究において、抗体はウェスタンブロッティング、酵素結合免疫吸着測定法（ELISA）、質量分析（MS）、タンパク質マイクロアレイなどの手法によるタンパク質の検出や定量に不可欠なツールです。高性能の研究用抗体は、翻訳後修飾（PTM）、タンパク質間相互作用（PPI）、タンパク質の細胞内局在を正確に研究することを可能にします。研究用抗体や試薬は、合成生物学やCRISPR/Cas9遺伝子編集技術における現在進行中の技術革新に後押しされ、ライフサイエンス応用において不可欠なツールであり続けています。これらの進歩は、生物学と疾病メカニズムの理解をかつてない精度で形成し続けています。

エンドユーザー：製薬・バイオテクノロジー企業における研究用抗体・試薬の使用拡大

学術・研究機関では、様々な種類の生物医療的研究や臨床研究のために抗体や試薬を主に必要としています。大学、医療部、研究機関などでは、免疫学、細胞生物学、分子生物学、生化学などの研究を促進するため、包括的なキットや特異性の高い抗体を好んで使用しています。契約研究機関（CRO）は、前臨床と臨床研究において抗体と試薬を使用することが増えています。主にCROはアッセイにおける高感度と信頼性を重視し、ハイスループットスクリーニングの効率を最適化する試薬を好んで使用しています。製薬会社やバイオテクノロジー企業は、医薬品開発や治療介入に抗体・試薬を幅広く活用しています。

地域別洞察

南北アメリカは、製薬企業やバイオテクノロジー企業による研究開発活動への多額の投資と複数の研究機関の存在を特徴とする、非常に発展途上の地域です。さらに、特許を取得した科学研究が最近増加していることも、南北アメリカにおける研究用抗体・試薬の需要を高めています。先進的な研究機器やツールによるバイオテクノロジー研究開発を拡大するための政府の重要なイニシアティブや投資は、アジア太平洋における研究用抗体・試薬市場の成長を促進すると期待されています。2021年5月、オーストラリア政府は、オーストラリアのバイオテクノロジーと医療技術セグメントへの投資を奨励するため、パテントボックス税制優遇制度に2億640万米ドルを拠出しました。アジアの膨大な人口、専門的な臨床試験センターへの投資への注力、臨床試験に対する政府の支援は、この地域が臨床試験を成功させるハブとして評価されている大きな要因です。欧州、中東、アフリカ（欧州、中東・アフリカ）地域では、ライフサイエンス産業の継続的な発展により、研究用抗体・試薬市場が大きく成長しています。英国政府によると、同国の健全なライフサイエンス部門は、英国経済に年間660億米ドル以上、22万人の雇用に貢献しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは研究用抗体・試薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、研究用抗体・試薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.研究用抗体・試薬市場の市場規模と予測は？

2.研究用抗体・試薬市場の予測期間中に投資を検討すべき製品、用途は何か？

3.研究用抗体・試薬市場の技術動向と規制枠組みは？

4.研究用抗体・試薬市場における主要ベンダーの市場シェアは？

5.研究用抗体・試薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬企業やバイオ医薬品企業による調査活動の増加
    • プロテオミクスとゲノミクス調査の人気の高まり
    • 個別化医療とタンパク質治療における研究用抗体・試薬の新たな動向
  • 抑制要因
    • 抗体開発プロセスの高コスト
  • 機会
    • 研究用抗体・試薬における研究開発の強化
    • 新たなバイオマーカーの発見への注目が高まる
  • 課題
    • 研究用抗体・試薬の品質に関する懸念と再現可能な結果の欠如
• 市場セグメンテーション分析
  • 製品：標的タンパク質の検出と定量化のための抗体の人気が高まっている
  • 技術：免疫表現型解析のためのフローサイトメトリーにおける研究用抗体・試薬の使用増加
  • 適応症：感染症の病原体同定における研究用抗体・試薬の応用拡大
  • 用途：特定の治療標的に合わせた医薬品開発のための調査抗体と試薬の利用増加
  • エンドユーザー：製薬とバイオテクノロジー企業全体で研究用抗体・試薬の使用を拡大
• 市場動向分析
  • 医薬品の発見に対する政府の投資の増加と、南北アメリカ地域における大手企業の強固な基盤
  • アジア太平洋における医療インフラの改善と生命科学調査への投資増加
  • ゲノミクスセグメントの研究開発に対する政府の支援の拡大と欧州、中東、アフリカ地域における大手バイオテクノロジー企業の強固な基盤
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 研究用抗体・試薬市場：製品別

• イントロダクション
• 抗体
• 試薬

第7章 研究用抗体・試薬市場：技術別

• イントロダクション
• 酵素免疫測定法
• フローサイトメトリー
• 免疫蛍光
• 免疫組織化学
• 免疫沈降法
• ウエスタンブロッティング

第8章 研究用抗体・試薬市場：適応症別

• イントロダクション
• 免疫学
• 感染症
• 神経生物学
• 腫瘍学
• 幹細胞

第9章 研究用抗体・試薬市場：用途別

• イントロダクション
• 医薬品開発
• ゲノミクス
• プロテオミクス

第10章 研究用抗体・試薬市場：エンドユーザー別

• イントロダクション
• 学術・研究機関
• 契約研究機関
• 製薬・バイオテクノロジー

第11章 南北アメリカの研究用抗体・試薬市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の研究用抗体・試薬市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの研究用抗体・試薬市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RESEARCH ANTIBODIES & REAGENTS MARKET RESEARCH PROCESS
• FIGURE 2. RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. RESEARCH ANTIBODIES & REAGENTS MARKET DYNAMICS
• FIGURE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. RESEARCH ANTIBODIES & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. RESEARCH ANTIBODIES & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RESEARCH ANTIBODIES & REAGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 83. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 84. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 85. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 86. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 87. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 88. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 89. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 92. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 93. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 94. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 95. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 96. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 97. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 98. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 99. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 100. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 101. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 102. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 103. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 104. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 105. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 108. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 109. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 112. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 113. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 114. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 115. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 116. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 117. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 118. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 119. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 122. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 123. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 126. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 127. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 128. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 129. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 130. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 131. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 132. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 133. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 136. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 137. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 140. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 141. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 142. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 143. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 144. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 145. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 146. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 147. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 150. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 151. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 154. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 155. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 156. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 157. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 158. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 159. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 160. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 161. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 164. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 165. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 166. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 171. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 172. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 173. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 174. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 175. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 176. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 177. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 180. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 181. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 182. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 183. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 184. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 185. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 186. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 187. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 188. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 189. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 190. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 191. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 192. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 193. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 196. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 197. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 200. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 201. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 202. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 203. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 204. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 205. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 206. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 207. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 210. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 211. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 214. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 215. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 216. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 217. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 218. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 219. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 220. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 221. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 224. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 225. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 226. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 227. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 228. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 229. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 230. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 231. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 232. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 233. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 234. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 235. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 238. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 239. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 240. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 241. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 242. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 243. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 244. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 245. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 246. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 247. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 248. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 249. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 252. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 253. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 254. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 255. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 256. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 257. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 258. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 259. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 260. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 261. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 262. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 263. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 266. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 267. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 270. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 271. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 272. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 273. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 274. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 275. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 276. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 277. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 280. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 281. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 282. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 283. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 284. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 285. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 286. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 287. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 288. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 289. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 290. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 291. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 292. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 293. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 294. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 297. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 298. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 299. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 300. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 301. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 302. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 303. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 304. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 305. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 306. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 307. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 308. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 309. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 310. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 311. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
• TABLE 312. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
• TABLE 313. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
• TABLE 314. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
• TABLE 315. TAIWAN RESEARCH ANTIBODIES & REAGENTS MA

[197 Pages Report] The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030.

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

Product: Increasing popularity of antibodies for detection and quantification of target proteins

Antibodies, specialist proteins that detect foreign bodies such as bacteria and viruses, are fundamental in several immunoassay applications such as western blotting and flow cytometry. There are different types, such as monoclonal antibodies (mAbs), which are identical because they are produced by a kind of immune cell, all clones of a single parent cell, ensuring uniformity and high specificity. Polyclonal antibodies (pAbs) are derived from different B cell lines, resulting in a mixture of antibodies that identify distinct epitopes on the same antigen. Recombinant antibodies are derived from a broad mix of parental antibodies and are usually engineered to have a desired specificity. Reagents are crucial for biochemical assays, genetic processing, and other molecular biology techniques. The reagents group includes many elements, such as buffers, which are responsible for maintaining the pH of a solution, making them vital for many biological processes. Enzymes, proteins that speed up chemical reactions, are instrumental in breaking down, combining, or changing certain chemicals in the body. Fixatives preserve tissues from decay, which is beneficial in histology and pathology labs. Media & sera refer to the sustenance provided to cells under cell culture; the 'media' offer essential nutrients while 'sera' provide additional growth factors that help cells multiply. Probes are utilized predominantly in molecular biology and biochemistry to detect, identify, and isolate specific sequences in DNA or RNA. Solvents are substances, usually a liquid, used to dissolve a solute, resulting in a solution. Stains & dyes are chemicals used to enhance the contrast in the microscopic image or to make a microscopic image visible for observation. While both product segments occupy an essential position in the research context, they cater to different research needs. Antibodies lend themselves to the detection and quantification of target proteins, while reagents facilitate broader laboratory techniques, including DNA, RNA manipulation, biochemical reactions, and cell cultures.

Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping

Enzyme-linked Immunosorbent Assay (ELISA) is a procedure for quantifying and detecting specific antigens or antibodies in biological samples. ELISA is an advantageous technology due to its high sensitivity, specificity, and low cost, which suits research, diagnostic, and quality control applications in various fields, such as infectious disease testing and drug monitoring. Flow cytometry is a laser-based technology that permits concurrent measurement of multiple parameters on individual cells in a fast and efficient manner. It is commonly used for cell counting, sorting, immunophenotyping, and biomarker detection in immunology, oncology, hematology, and stem cell research. Immunofluorescence is a microscopy-based technique that uses fluorescently labeled antibodies to detect specific proteins or other biomolecules in cells and tissues. It offers high sensitivity, specificity, and spatial resolution for studying protein expression, localization, and interaction in fixed or live samples. Immunohistochemistry is an essential method for localizing proteins within tissue sections using specific antibodies conjugated with chromogenic or fluorescent markers. IHC is widely used in pathological diagnosis, research on cellular processes, and drug discovery efforts. Immunoprecipitation is a powerful method used to isolate target proteins from complex mixtures by using specific antibodies immobilized on solid support beads. IP can help study protein-protein interactions, post-translational modifications, and protein-nucleic acid interactions. Western blotting is a technique for catching specific proteins in complex samples based on their molecular weight using gel electrophoresis followed by antibody-based detection on membranes. It serves as a tool for protein expression analysis, validation of gene silencing or overexpression experiments, and diagnostic evaluations.

Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases

Immunology-based antibodies and reagents are paramount in allergy and asthma, autoimmune disease, and transplantation. In fighting infectious diseases, research antibodies are key tools in the identification and detection of pathogens by utilizing research antibodies to demonstrate the presence of specific antigens or antibodies in a patient's serum. Additionally, reagents are vital in cultivating viruses for vaccines and antiviral drug testing. Neurobiology needs antibodies and reagents, with research focusing on neurodegenerative diseases and brain injuries. Research antibodies have revolutionized the field of oncology and are widely employed in the targeted therapy of cancer, where monoclonal antibodies can bind to cancer cells, hindering their growth and proliferation. Their utility in immunohistochemistry allows for the detailed subtype classification of tumors. In the area of stem cell research, antibodies play an indispensable role in the determination of stem cell potency and differentiation status. Reagents are heavily used in cell culture to help the growth and differentiation of stem cells. Stem cell research has seen steady advancements in regenerative medicine and therapeutic cloning, largely fueled by the evolving applications of research antibodies and reagents.

Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets

In drug development, research antibodies and reagents are crucial in target identification, validation, and pre-clinical studies. They facilitate the identification of protein targets, accelerate therapeutic antibody generation, and support the evaluation of drug efficacy and safety. Genomics research relies on high-quality antibodies and reagents for techniques such as gene expression analysis, chromatin immunoprecipitation (ChIP), DNA methylation studies, and CRISPR/Cas9 gene editing. These tools help identify genes involved in diseases and enable a deeper understanding of genetic mechanisms. In proteomics research, antibodies are indispensable tools for protein detection and quantification through methods such as western blotting, enzyme-linked immunosorbent assay (ELISA), mass spectrometry (MS), or protein microarrays. High-performance research antibodies enable investigators to study post-translational modifications (PTMs), protein-protein interactions (PPIs), and cellular localization of proteins accurately. Research antibodies and reagents remain indispensable tools within life science applications driven by ongoing innovations in synthetic biology or CRISPR/Cas9 gene editing techniques. These advancements continue to shape our understanding of biology and disease mechanisms with unprecedented precision.

End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies

Academic & research institutions predominantly require antibodies & reagents for various types of biomedical and clinical research. Entities such as universities, medical schools, and governed research institutes prefer comprehensive kits and highly specific antibodies to facilitate research in immunology, cell biology, molecular biology, and biochemistry. Contract research organizations (CROs) increasingly use antibodies & reagents in their pre-clinical and clinical research. Primarily, CROs focus on high sensitivity and reliability in their assays and prefer reagents that optimize the efficiency of high-throughput screening. Pharmaceutical and biotechnology companies utilize antibodies and reagents extensively in drug development and therapeutic interventions.

Regional Insights

Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies & Reagents Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies & Reagents Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Alpha Teknova, Inc., Atlas Antibodies AB, Avantor, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux S.A., Cardinal Health, Inc., Cell Signaling Technology, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dovetail Genomics LLC, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GenScript Biotech Corporation, Honeywell International Inc., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Leinco Technologies, Inc., LifeSpan BioSciences, Inc., LobaChemie Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Antibodies
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

• Reagent
  • Buffers
  • Enzymes
  • Fixatives
  • Media & Sera
  • Probes
  • Solvents
  • Stains & Dyes
• Technology
  • Enzyme-linked Immunosorbent Assay
  • Flow Cytometry
  • Immunofluorescence
  • Immunohistochemistry
  • Immunoprecipitation
  • Western Blotting

• Indication
  • Immunology
  • Infectious Diseases
  • Neurobiology
  • Oncology
  • Stem Cells

• Application
  • Drug Development
  • Genomics
  • Proteomics

• End User
  • Academic & Research Institutions
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Research Antibodies & Reagents Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies & Reagents Market?

3. What are the technology trends and regulatory frameworks in the Research Antibodies & Reagents Market?

4. What is the market share of the leading vendors in the Research Antibodies & Reagents Market?

5. Which modes and strategic moves are suitable for entering the Research Antibodies & Reagents Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
    • 5.1.1.2. Rising popularity of proteomics and genomics research
    • 5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of antibody development processes
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D in research antibodies & reagents
    • 5.1.3.2. Rising focus on discovering novel biomarkers
  • 5.1.4. Challenges
    • 5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
  • 5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
  • 5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
  • 5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
  • 5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
• 5.3. Market Trend Analysis
  • 5.3.1. Increasing government investment for drug discovery coupled with robust foothold of major companies in Americas region
  • 5.3.2. Improving healthcare infrastructure and rising investment in life sciences research in the Asia-Pacific region
  • 5.3.3. Expanding government support for research and development in the field of genomics and strong foothold of major biotechnology companies in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Research Antibodies & Reagents Market, by Product

• 6.1. Introduction
• 6.2. Antibodies
• 6.3. Reagent

7. Research Antibodies & Reagents Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme-linked Immunosorbent Assay
• 7.3. Flow Cytometry
• 7.4. Immunofluorescence
• 7.5. Immunohistochemistry
• 7.6. Immunoprecipitation
• 7.7. Western Blotting

8. Research Antibodies & Reagents Market, by Indication

• 8.1. Introduction
• 8.2. Immunology
• 8.3. Infectious Diseases
• 8.4. Neurobiology
• 8.5. Oncology
• 8.6. Stem Cells

9. Research Antibodies & Reagents Market, by Application

• 9.1. Introduction
• 9.2. Drug Development
• 9.3. Genomics
• 9.4. Proteomics

10. Research Antibodies & Reagents Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutions
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology

11. Americas Research Antibodies & Reagents Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Research Antibodies & Reagents Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Research Antibodies & Reagents Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
  • 14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
  • 14.3.3. Danaher to Acquire Abcam plc
  • 14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
  • 14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
  • 14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
  • 14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
  • 14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
  • 14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
  • 14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio